Enzyme-linked immunosorbent assay (ELISA) validated that TAMs with Id1 depletion, isolated from CRC patient tumor tissues, MC38-derived tumor tissues or induced from BMDMs, showed increased CCL4 protein abundance (Fig. 5e; Supplementary Fig. 4b, c). This evidence concerns the gene CCL4 and colorectal carcinoma.